Bacil Pharma Ltd

BSE :524516 NSE :- Sector : Pharmac..
43.61
Change: -0.89(-2.00%)
No Graph Available
52 week Low
8.31
52 week High
62.56
Day low
43.61
Day high
45.39
Prev Close
44.50
Open
45.39
6M return
179.01%
1Y return
424.16%
MCap(Rs. in Cr.)
25.69
Total Volume
265
Face Value : 10
Listed Since
PE Ratio

Is the price-earnings ratio for valuing a company that measures its current share price relative to its earnings per share.

P/E RATIO
0
EPS

The earnings per share ratio is a portion of company's net profit allocated for each outstanding share. It is calculated by deducting preferred stock divided from the net income of the company divided by the number of outstanding shares.

EPS
0
PRICE/BOOK

Price-to-book ratio is used to compared the company's current market price with its book value.

PRICE/BOOK
Deliverable

These are the acutal number of shares that are traded on delivery based, meaning transfered from one person to another during the day's trade.

DELIVERABLES
0
DIV YIELD.(%)

Dividend Yield measures the quantum of cash dividends paid to shareholders in a financial year relative to the market value of the per share.

DIV YIELD.(%)
0

Company Details

Check out the key parameters of the company to understand the financial health and stock performance

Key Level

Resistance 1
-
Resistance 2
-
Support 1
-
Support 2
-

Moving Average

20 Days
-
50 Days
-
100 Days
-
200 Days
-
Growth in 3 years

Sales


Sales Industry Avg


PAT


PAT Industry Avg


No data available
No data available


Relative to Sensex rtn in 3 year


Relative to Nifty rtn in 3 year


Relative to top 3 MF rtn in 3 year


2016 2014 2014
Sales 59.91 59.91 59.91
Gross Profit 60.14 60.14 60.14
Operating Profit 6.14 6.14 6.14
Sales 59.91 59.91 59.91
Gross Profit 60.14 60.14 60.14
Operating Profit 6.14 6.14 6.14

Peer Companies

A quick glance on how stocks from the same sector have performed along with some key parameters

Bacil Pharma
43.61
Change: -0.89 (-2.00%)
1 Year return
424.16%
Risk (Std Dev)
0.29%
PE Ratio
73.92
MCap( in Cr.)
25.69
Shukra Pharma.
205.60
Change: 3.05 (1.51%)
1 Year return
319.08%
Risk (Std Dev)
0.48%
PE Ratio
109.95
MCap( in Cr.)
900.28
Oxygenta Pharma
82.56
Change: -1.68 (-1.99%)
1 Year return
159.46%
Risk (Std Dev)
0.28%
PE Ratio
NM
MCap( in Cr.)
305.34
Everest Organics
243.65
Change: -12.80 (-4.99%)
1 Year return
78.89%
Risk (Std Dev)
0.35%
PE Ratio
NM
MCap( in Cr.)
249.03
Pharmaids Pharma
61.94
Change: 0.00 (0.00%)
1 Year return
19.83%
Risk (Std Dev)
0.16%
PE Ratio
NM
MCap( in Cr.)
218.45
View More

Return Calculator

This tools helps you project your potential return on investments for the given stock, for a specified amount over a per-defined period of time.

 

If I had made
investment of  
in
Months Ago
My investment would be worth 0 with a of 0%

News

Stay tuned to the latest developments and happenings in the company.

Bacil Pharma reports standalone net loss of Rs 0.06 crore in the December 2024 quarter

Net Loss of Bacil Pharma reported to Rs 0.06 crore in the quarter ended December 2024 as against net loss of Rs 0.02 crore during the previous quarter....

22 Jan 2025 07:27

Bacil Pharma to discuss results

Bacil Pharma will hold a meeting of the Board of Directors of the Company on 21 January 2025.Powered by Capital Market - Live News</p....

14 Jan 2025 14:13

Bacil Pharma reports standalone net profit of Rs 0.48 crore in the September 2024 quarter

Net profit of Bacil Pharma reported to Rs 0.48 crore in the quarter ended September 2024 as against net loss of Rs 0.01 crore during the previous quar....

24 Oct 2024 07:28

Bacil Pharma to convene board meeting

Bacil Pharma will hold a meeting of the Board of Directors of the Company on 23 October 2024.Powered by Capital Market - Live News</p....

17 Oct 2024 12:34

Bacil Pharma schedules board meeting

Bacil Pharma will hold a meeting of the Board of Directors of the Company on 15 October 2024.Powered by Capital Market - Live News</p....

11 Oct 2024 10:31

Bacil Pharma reports standalone net loss of Rs 0.03 crore in the June 2024 quarter

Net loss of Bacil Pharma reported to Rs 0.03 crore in the quarter ended June 2024 as against net profit of Rs 0.02 crore during the previous quarter e....

14 Aug 2024 17:58

View More
Subscribe for our
newsletter
Open Account Now